Clinical Trials Logo

Clinical Trial Summary

Adenoviruses have been linked to severe hepatitis in children. They are non-enveloped, icosahedral viruses of medium size (90-100 nm) (5). Adenoviruses usually infect the respiratory tract, eyes, urinary tract, intestines, and central nervous system (6). These diseases are


Clinical Trial Description

Hepatitis is an inflammatory reaction of the liver that lead to a spectrum of health problems (1). Hepatitis results from a variety of causes, both infectious and non-infectious. Infectious agents include viruses and parasites. Non-infectious causes include drugs and toxic agents (2). Viral hepatitis remains an important challenge to human health, making it a leading cause of death globally. The absolute burden of viral hepatitis is increasing gradually (3). The most common types of viral hepatitis are hepatitis A, B, and C. The other types are hepatitis D and E, which are less frequent (2). Epstein-Barr virus (EBV) and cytomegalovirus (CMV) infections are common and are associated with liver manifestations (4). Adenoviruses have been linked to severe hepatitis in children. They are non-enveloped, icosahedral viruses of medium size (90-100 nm) (5). Adenoviruses usually infect the respiratory tract, eyes, urinary tract, intestines, and central nervous system (6). These diseases are generally self-limiting, but severe infections can occur in immunocompromised hosts (7). Children are more susceptible to HAdVs infection because their immune systems are less developed. HAdVs cause a range of symptoms, including colds, vomiting, diarrhea, and sometimes pneumonia, but rarely hepatitis in immunocompromised patients (8) In April 2022, the WHO has reported severe acute hepatitis outbreaks among children from 11 countries across Europe and America, which have induced great public concern, HAdV is presumed to be a possible etiology of this outbreak (9). The diagnostic methods for adenovirus include antigen detection, polymerase chain reaction (PCR), virus isolation, and serology (10). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05693714
Study type Observational
Source Assiut University
Contact Rana Refaat
Phone 01016846749
Email 14223863@med.aun.edu.eg
Status Not yet recruiting
Phase
Start date January 20, 2023
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT01168570 - Progression of Renal Amyloidosis of FMF and Relation to Serum SAA Level N/A
Completed NCT03548753 - Use of FFR-CT in Stable Intermediate Chest Pain Patients With Severe Coronary Calcium Score
Completed NCT03138772 - Tracking CF Lung Disease Through the Early Years: Utility of the LCI
Completed NCT00233649 - DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines Phase 4
Completed NCT06433154 - Arthroscopy of the Temporomandibular Joint. On Jaw Mobility, Pain and HRQoL
Not yet recruiting NCT06448715 - Real-World Treatment Study of Soliris (Eculizumab)
Recruiting NCT03728829 - Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
Completed NCT00745966 - Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder N/A
Recruiting NCT03253536 - Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma N/A
Completed NCT02922205 - Stapler Post-market Observational Study